Medicine guide
Palforzia
·
- Prescription status not stated
- Everything that fits nowhere else, such as contrast media
- Active substance
- Defatted powder of Arachis hypogaea L., semen (peanuts)
- Made by
- Stallergenes
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Palforzia is indicated for the treatment of patients aged 1 to 17 years with a confirmed diagnosis of peanut allergy. Palforzia may be continued in patients 18 years of age and older. Palforzia should be used in conjunction with a peanut-avoidant diet.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Stallergenes |
|---|---|
| Active substance | Defatted powder of Arachis hypogaea L., semen (peanuts) |
| Used in | Everything that fits nowhere else, such as contrast media |
| Classification | V01 · Everything that fits nowhere else, such as contrast media |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Authorised on | 2020-12-17 |
| Last updated by the regulator | 2026-02-12 |
| EMA product number | EMEA/H/C/004917 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).